US 11883408
Reboxetine to treat narcolepsy
granted A61KA61K31/5375A61P
Quick answer
US patent 11883408 (Reboxetine to treat narcolepsy) held by AXSOME THERAPEUTICS, INC. expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AXSOME THERAPEUTICS, INC.
- Grant date
- Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/5375, A61P, A61P25/02, A61P25/20